Receptors, Phospholipase A2
"Receptors, Phospholipase A2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface receptors that bind to and internalize SECRETED PHOSPHOLIPASES A2. Although primarily acting as scavenger receptors, these proteins may also play a role in intracellular signaling. Soluble forms of phospholipase A2 receptors occur through the action of proteases and may a play a role in the inhibition of extracellular phospholipase activity.
| Descriptor ID |
D054507
|
| MeSH Number(s) |
D12.776.543.750.783
|
| Concept/Terms |
Receptors, Phospholipase A2- Receptors, Phospholipase A2
- Receptor, Phospholipase A2
- PLA(2) Receptor
- Phospholipase A2 Receptor
- Phospholipase A2 Receptors
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Phospholipase A2".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Phospholipase A2".
This graph shows the total number of publications written about "Receptors, Phospholipase A2" by people in this website by year, and whether "Receptors, Phospholipase A2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 2 | 0 | 2 |
| 2018 | 4 | 2 | 6 |
| 2019 | 1 | 2 | 3 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Phospholipase A2" by people in Profiles.
-
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach. Appl Immunohistochem Mol Morphol. 2020 May/Jun; 28(5):376-383.
-
Membranous Nephropathy Posttransplantation: An Update of the Pathophysiology and Management. Transplantation. 2019 10; 103(10):1990-2002.
-
A First Step toward a New Approach to Treating Membranous Nephropathy. N Engl J Med. 2019 07 04; 381(1):86-88.
-
Phospholipase A2 receptor-associated membranous nephropathy in a patient with IgG4-related disease: A case report. Medicine (Baltimore). 2019 May; 98(20):e15616.
-
Antibodies to M-type phospholipase receptor and immunological remission in treatment-resistant and relapsing membranous nephropathy. Kidney Int. 2018 10; 94(4):829-830.
-
Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy. J Nephrol. 2018 Dec; 31(6):899-905.
-
Membranous nephropathy with light chain restricted deposits. Nephrology (Carlton). 2018 Aug; 23(8):791-796.
-
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain. J Nephrol. 2018 08; 31(4):543-550.
-
PLA2R related primary membranous nephropathy in a hepatitis C positive patient. Nephrology (Carlton). 2018 03; 23(3):288.
-
The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial. J Korean Med Sci. 2018 Feb 26; 33(9):e74.